/ Modified feb 22, 2018 4:30 p.m.

Audit: Arizona Owes Feds Millions in Uncollected Drug Rebates

Report recommends the state account for the $37 million shortfall.

Via Pixabay

Arizona may have to pay the federal government to make up for money the state should have collected from pharmaceutical companies.

The federal government expects Arizona and other states to get rebates for expensive, brand-name prescription drugs that go to Medicaid patients. But officials with Arizona's Medicaid program, known as AHCCCS, say changes in the health care system between 2010 and 2013 led to an uncollected amount totaling almost $37 million.

AHCCCS spokeswoman Heidi Capriotti said the state's system, which is designed to collect the rebates, is being adjusted to account for the shortfall.

"During that time frame, AHCCCS collected 94 percent of the eligible rebates at a total of about $650 million, and we continue to make process changes to our system to collect the remainder of those rebates," she said.

A U.S. Health and Human Services audit uncovered the problem. Its report recommends Arizona take immediate steps to ensure that all physician-administered drugs eligible for rebates are processed correctly.

By posting comments, you agree to our
AZPM encourages comments, but comments that contain profanity, unrelated information, threats, libel, defamatory statements, obscenities, pornography or that violate the law are not allowed. Comments that promote commercial products or services are not allowed. Comments in violation of this policy will be removed. Continued posting of comments that violate this policy will result in the commenter being banned from the site.

By submitting your comments, you hereby give AZPM the right to post your comments and potentially use them in any other form of media operated by this institution.
Arizona Public Media broadcast stations are licensed to the Arizona Board of Regents. Arizona Public Media and AZPM are registered trademarks of the Arizona Board of Regents.
The University of Arizona